Adalvo Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ADALVO, and what generic alternatives to ADALVO drugs are available?
ADALVO has one approved drug.
There is one US patent protecting ADALVO drugs.
There are forty-one patent family members on ADALVO drugs in twenty-four countries and twelve supplementary protection certificates in four countries.
Drugs and US Patents for Adalvo
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Adalvo | ONSOLIS | fentanyl citrate | FILM;BUCCAL | 022266-005 | Jul 16, 2009 | DISCN | No | No | 9,597,288 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Adalvo | ONSOLIS | fentanyl citrate | FILM;BUCCAL | 022266-004 | Jul 16, 2009 | DISCN | No | No | 9,597,288 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Adalvo | ONSOLIS | fentanyl citrate | FILM;BUCCAL | 022266-002 | Jul 16, 2009 | DISCN | No | No | 9,597,288 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Adalvo | ONSOLIS | fentanyl citrate | FILM;BUCCAL | 022266-003 | Jul 16, 2009 | DISCN | No | No | 9,597,288 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Adalvo
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Adalvo | ONSOLIS | fentanyl citrate | FILM;BUCCAL | 022266-005 | Jul 16, 2009 | 6,159,498 | ⤷ Try a Trial |
Adalvo | ONSOLIS | fentanyl citrate | FILM;BUCCAL | 022266-004 | Jul 16, 2009 | 6,159,498 | ⤷ Try a Trial |
Adalvo | ONSOLIS | fentanyl citrate | FILM;BUCCAL | 022266-002 | Jul 16, 2009 | 6,159,498 | ⤷ Try a Trial |
Adalvo | ONSOLIS | fentanyl citrate | FILM;BUCCAL | 022266-002 | Jul 16, 2009 | 7,579,019 | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for Adalvo Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Serbia | 54764 | ⤷ Try a Trial |
Hong Kong | 1131344 | ⤷ Try a Trial |
European Patent Office | 3067044 | ⤷ Try a Trial |
Norway | 20170380 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Adalvo Drugs
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
1769785 | C300521 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: FENTANYL; REG NO/DATE: EU/2/11/127/001 20111006 |
1769785 | C300522 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: FENTANYL EN DOSERINGSAPPLICATOR; REG. NO/DATE: EU/2/11/127/001 20111006 |
1635783 | 300653 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: FENTANYL IN ELKE DOOR HET BASISOCTROOI BESCHERMDE VERSCHIJNINGSVORM; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100906 |
1635783 | C300653 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: FENTANYL IN ELKE DOOR HET BASISOCTROOI BESCHERMDE VERSCHIJNINGSVORM; REGISTRATION NO/DATE: EU/1/10/644/001-004 20100906 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.